tiprankstipranks
Lexaria Bioscience Corp. (LEXX)
:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Financial Statements

191 Followers

Lexaria Bioscience Financial Overview

Lexaria Bioscience's market cap is currently ―. The company's EPS TTM is $-0.489; its P/E ratio is ―; Lexaria Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 24Aug 24May 24Feb 24Nov 23
Income Statement-
Total Revenue$ 183.92K$ 84.00K$ 84.00K$ 145.00K$ 151.28K
Gross Profit$ 181.20K$ 84.00K$ 84.00K$ 145.00K$ 146.46K
EBIT$ -2.71M$ -2.19M$ -1.78M$ -652.73K$ -1.19M
EBITDA$ -2.67M$ -2.17M$ -1.77M$ -636.80K$ -1.16M
Net Income Common Stockholders$ -2.70M$ -2.18M$ -1.78M$ -652.73K$ -1.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.12M$ 6.56M$ 8.51M$ 4.79M$ 2.03M
Total Assets$ 9.79M$ 8.87M$ 10.02M$ 6.35M$ 3.63M
Total Debt$ 130.73K$ 137.37K$ 142.59K$ 148.88K$ 155.07K
Net Debt$ -7.99M$ -6.42M$ -8.36M$ -4.64M$ -1.87M
Total Liabilities$ 399.72K$ 1.21M$ 271.38K$ 204.20K$ 254.04K
Stockholders Equity$ 9.77M$ 8.04M$ 10.12M$ 6.52M$ 3.74M
Cash Flow-
Free Cash Flow$ -2.76M$ -1.96M-$ -676.60K$ -1.22M
Operating Cash Flow$ -2.73M$ -1.89M$ -1.27M$ -619.61K$ -1.18M
Investing Cash Flow$ -37.80K$ -69.59K$ -22.00K$ -56.99K$ -40.03K
Financing Cash Flow$ 4.35M-$ 5.04M$ 3.45M$ 1.82M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

Lexaria Bioscience Debt to Assets

Lexaria Bioscience Cash Flow

Lexaria Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis